Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C McNeil

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|March 19, 1997
The new Pap technologies: where they standC McNeil
Journal of the National Cancer Institute|January 29, 1999
Using HER2 to choose chemotherapy in breast cancer: is it ready for the clinic?C McNeil
Journal of the National Cancer Institute|September 25, 1998
New Pap test technologies hit heavy seas but sales keep flyingC McNeil
Journal of the National Cancer Institute|March 5, 1998
Non-Hodgkin's lymphoma trials in elderly look beyond CHOPC McNeil
Journal of the National Cancer Institute|March 14, 1998
Evidence mounts that Epstein-Barr test may help diagnose AIDS brain lymphomaC McNeil
Journal of the National Cancer Institute|May 18, 1999
Can guidelines be integrated into everyday practice? The NCCN in year 4. National Comprehensive Cancer NetworkC McNeil
Journal of the National Cancer Institute|January 29, 1999
How should HER2 status be determined?C McNeil
Journal of the National Cancer Institute|September 6, 1995
Ovarian cancer screening: new trial tries new twistsC McNeil
Journal of the National Cancer Institute|June 19, 1996
Topotecan: after FDA and ASCO, what's next?C McNeil
Journal of the National Cancer Institute|August 2, 1995
In the clinic: where paclitaxel and docetaxel standC McNeil
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|March 19, 1997
The new Pap technologies: where they standC McNeil
Journal of the National Cancer Institute|January 29, 1999
Using HER2 to choose chemotherapy in breast cancer: is it ready for the clinic?C McNeil
Journal of the National Cancer Institute|September 25, 1998
New Pap test technologies hit heavy seas but sales keep flyingC McNeil
Journal of the National Cancer Institute|March 5, 1998
Non-Hodgkin's lymphoma trials in elderly look beyond CHOPC McNeil
Journal of the National Cancer Institute|March 14, 1998
Evidence mounts that Epstein-Barr test may help diagnose AIDS brain lymphomaC McNeil
Journal of the National Cancer Institute|May 18, 1999
Can guidelines be integrated into everyday practice? The NCCN in year 4. National Comprehensive Cancer NetworkC McNeil
Journal of the National Cancer Institute|January 29, 1999
How should HER2 status be determined?C McNeil
Journal of the National Cancer Institute|September 6, 1995
Ovarian cancer screening: new trial tries new twistsC McNeil
Journal of the National Cancer Institute|June 19, 1996
Topotecan: after FDA and ASCO, what's next?C McNeil
Journal of the National Cancer Institute|August 2, 1995
In the clinic: where paclitaxel and docetaxel standC McNeil
Pageof 13